chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given a dose of the vaccine from an expired vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given a dose of the vaccine from an expired vial) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given a dose of the vaccine from an expired vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was given a dose of the vaccine from an expired vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-268121 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Tremor
Clinical narrative: Feeling hot and cold; Shaking; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) and TREMOR (Shaking) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) and TREMOR (Shaking). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) and TREMOR (Shaking) outcome was unknown.            Concomitant medication use was not provided.  No Treatment information was provided.   This case was linked to MOD-2021-235424 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: Dose administered after temperature excursion; Temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion). On 23-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. The medical assistant had a 2 vials that were in freezer and gone temperature excursion due to a power outage. Hcp said that  fridge had a temperature excursion but not the freezer as the alarms never went off for the freezer.  Shipment received for those 2 vials was more than 24 hours.The date of temperature excursion was 17Jul2021.1 vial opened and punctured on 23Jul2021 and 5 doses were administered from it. Treatment medications was not provided by the reporter
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered outside of allowed storage and handling guidelines; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered outside of allowed storage and handling guidelines) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered outside of allowed storage and handling guidelines). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered outside of allowed storage and handling guidelines) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details was not reported by the reporter. Treatment details was not reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-1 test, Taste disorder
Clinical narrative: taste has been altered; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (taste has been altered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TASTE DISORDER (taste has been altered). At the time of the report, TASTE DISORDER (taste has been altered) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-1 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported. No treatment medications were provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported No concomitant medication was reported   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Varicella
Clinical narrative: developed "full blown chickenpox"; unable to receive the second dose in the Moderna series; diagnosed with chickenpox; This spontaneous case was reported by a pharmacist and describes the occurrence of VARICELLA (developed "full blown chickenpox"), PRODUCT DOSE OMISSION ISSUE (unable to receive the second dose in the Moderna series) and VARICELLA (diagnosed with chickenpox) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced VARICELLA (diagnosed with chickenpox). On 16-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (unable to receive the second dose in the Moderna series). On an unknown date, the patient experienced VARICELLA (developed "full blown chickenpox"). At the time of the report, VARICELLA (developed "full blown chickenpox"), PRODUCT DOSE OMISSION ISSUE (unable to receive the second dose in the Moderna series) and VARICELLA (diagnosed with chickenpox) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.     No concomitant medication reported.  No treatment medication reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Feeling abnormal, Malaise, Myalgia, Neuralgia
Clinical narrative: Malaise; Discomfort; Feeling abnormal; Pain in extremity; Myalgia; Pyrexia; Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs; Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs), NEURALGIA (Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away), MALAISE (Malaise), DISCOMFORT (Discomfort) and FEELING ABNORMAL (Feeling abnormal) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SIMVASTATIN, VITAMIN D [VITAMIN D NOS] and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PARAESTHESIA (Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs) and NEURALGIA (Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away). On an unknown date, the patient experienced MALAISE (Malaise), DISCOMFORT (Discomfort), FEELING ABNORMAL (Feeling abnormal), PAIN IN EXTREMITY (Pain in extremity), MYALGIA (Myalgia) and PYREXIA (Pyrexia). The patient was treated with GABAPENTIN in March 2021 for Adverse event, at a dose of 100 mcg, 3 at night and 1 in the morning. At the time of the report, PARAESTHESIA (Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs) and NEURALGIA (Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away) was resolving and MALAISE (Malaise), DISCOMFORT (Discomfort), FEELING ABNORMAL (Feeling abnormal), PAIN IN EXTREMITY (Pain in extremity), MYALGIA (Myalgia) and PYREXIA (Pyrexia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Consumer mentioned treatment with Gabapentin helped some events, but she had to increase the dosage to 3 at night and 1 in the morning. She stated that she was still miserable night and day. She had an upcoming appointment with the neurologist to do a nerve conduction test and may undergo a small nerve biopsy test.  Consumer did not provide consent to Safety to follow up with her healthcare provider.   This case was linked to MOD-2021-268369 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: Malaise; Discomfort; Feeling abnormal; Pain in extremity; Myalgia; Pyrexia; Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs; Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs), NEURALGIA (Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away), MALAISE (Malaise), DISCOMFORT (Discomfort) and FEELING ABNORMAL (Feeling abnormal) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SIMVASTATIN, VITAMIN D [VITAMIN D NOS] and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PARAESTHESIA (Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs) and NEURALGIA (Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away). On an unknown date, the patient experienced MALAISE (Malaise), DISCOMFORT (Discomfort), FEELING ABNORMAL (Feeling abnormal), PAIN IN EXTREMITY (Pain in extremity), MYALGIA (Myalgia) and PYREXIA (Pyrexia). The patient was treated with GABAPENTIN in March 2021 for Adverse event, at a dose of 100 mcg, 3 at night and 1 in the morning. At the time of the report, PARAESTHESIA (Tingling in her feet/had a tingling and zapping sensation all over her body such as her head, cheeks, eyelids, sides, buttocks, and thighs) and NEURALGIA (Constant nerve pain all over/ when it is in her face, she can touch it and rub it so it goes away) was resolving and MALAISE (Malaise), DISCOMFORT (Discomfort), FEELING ABNORMAL (Feeling abnormal), PAIN IN EXTREMITY (Pain in extremity), MYALGIA (Myalgia) and PYREXIA (Pyrexia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Consumer mentioned treatment with Gabapentin helped some events, but she had to increase the dosage to 3 at night and 1 in the morning. She stated that she was still miserable night and day. She had an upcoming appointment with the neurologist to do a nerve conduction test and may undergo a small nerve biopsy test.  Consumer did not provide consent to Safety to follow up with her healthcare provider.   This case was linked to MOD-2021-268369 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: first shot ( given in his left arm) was worse that the second shot ( given in his right arm).; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (first shot ( given in his left arm) was worse that the second shot ( given in his right arm).) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In December 2020, the patient experienced VACCINATION COMPLICATION (first shot ( given in his left arm) was worse that the second shot ( given in his right arm).). At the time of the report, VACCINATION COMPLICATION (first shot ( given in his left arm) was worse that the second shot ( given in his right arm).) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication were reported.  No Treatment medications were reported.   This case was linked to MOD-2021-266663 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Myalgia, Paraesthesia, Pyrexia
Clinical narrative: Didn't feel well; Was achy for a couple of days/A sharp pain in her hand, her shoulders will have some pain, then eventually it goes away; it increased after the second dose as in the beginning it was in her feet and now it has increased to all over her body/a "nervey, numby, zapping, and tingling feeling" that she feels all the time; Miserable night and day/Constantly very uncomfortable; A little temperature; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well), MYALGIA (Was achy for a couple of days/A sharp pain in her hand, her shoulders will have some pain, then eventually it goes away), PARAESTHESIA (it increased after the second dose as in the beginning it was in her feet and now it has increased to all over her body/a "nervey, numby, zapping, and tingling feeling" that she feels all the time), FEELING ABNORMAL (Miserable night and day/Constantly very uncomfortable) and PYREXIA (A little temperature) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 012M20A) for COVID-19 vaccination.     No Relevant Medical History was provided.  Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN B12 NOS and SIMVASTATIN for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Didn't feel well), MYALGIA (Was achy for a couple of days/A sharp pain in her hand, her shoulders will have some pain, then eventually it goes away), PARAESTHESIA (it increased after the second dose as in the beginning it was in her feet and now it has increased to all over her body/a "nervey, numby, zapping, and tingling feeling" that she feels all the time), FEELING ABNORMAL (Miserable night and day/Constantly very uncomfortable) and PYREXIA (A little temperature). The patient was treated with GABAPENTIN at a dose of 100 microgram. At the time of the report, MALAISE (Didn't feel well), MYALGIA (Was achy for a couple of days/A sharp pain in her hand, her shoulders will have some pain, then eventually it goes away), PARAESTHESIA (it increased after the second dose as in the beginning it was in her feet and now it has increased to all over her body/a "nervey, numby, zapping, and tingling feeling" that she feels all the time), FEELING ABNORMAL (Miserable night and day/Constantly very uncomfortable) and PYREXIA (A little temperature) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: increased heart rate after 2 or 3 days after getting 2nd dose normal?; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (increased heart rate after 2 or 3 days after getting 2nd dose normal?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (increased heart rate after 2 or 3 days after getting 2nd dose normal?). At the time of the report, HEART RATE INCREASED (increased heart rate after 2 or 3 days after getting 2nd dose normal?) outcome was unknown.            Concomitant medicine and Medical history were not provided. Treatment medicine were not reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurt). At the time of the report, VACCINATION SITE PAIN (Arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: Arm swelling; Arm rash; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelling) and RASH (Arm rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078czia) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm swelling) and RASH (Arm rash). At the time of the report, PERIPHERAL SWELLING (Arm swelling) and RASH (Arm rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna was given to a 16 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna was given to a 16 year old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 034CA21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna was given to a 16 year old). On 14-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna was given to a 16 year old) had resolved. Not applicable      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported.   No treatment drugs were reported.   This case was linked to MOD-2021-256223 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site discomfort, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: rash is sensitive to touch; Rash itches; Hot rash at the injection site; Area of the rash itches; Hot rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (rash is sensitive to touch), RASH PRURITIC (Rash itches), VACCINATION SITE WARMTH (Hot rash at the injection site), VACCINATION SITE PRURITUS (Area of the rash itches) and VACCINATION SITE RASH (Hot rash at the injection site) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced VACCINATION SITE DISCOMFORT (rash is sensitive to touch), RASH PRURITIC (Rash itches), VACCINATION SITE WARMTH (Hot rash at the injection site), VACCINATION SITE PRURITUS (Area of the rash itches) and VACCINATION SITE RASH (Hot rash at the injection site). At the time of the report, VACCINATION SITE DISCOMFORT (rash is sensitive to touch), RASH PRURITIC (Rash itches), VACCINATION SITE WARMTH (Hot rash at the injection site), VACCINATION SITE PRURITUS (Area of the rash itches) and VACCINATION SITE RASH (Hot rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Product availability issue, Product dose omission issue
Clinical narrative: He received the 1st dose of the Moderna vaccine in mid March 2021 and was unable to receive the 2nd dose because of unavailability; unable to receive the 2nd dose because of unavailability; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (He received the 1st dose of the Moderna vaccine in mid March 2021 and was unable to receive the 2nd dose because of unavailability) and PRODUCT AVAILABILITY ISSUE (unable to receive the 2nd dose because of unavailability) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (He received the 1st dose of the Moderna vaccine in mid March 2021 and was unable to receive the 2nd dose because of unavailability) and PRODUCT AVAILABILITY ISSUE (unable to receive the 2nd dose because of unavailability). At the time of the report, PRODUCT DOSE OMISSION ISSUE (He received the 1st dose of the Moderna vaccine in mid March 2021 and was unable to receive the 2nd dose because of unavailability) and PRODUCT AVAILABILITY ISSUE (unable to receive the 2nd dose because of unavailability) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, Vaccination site lymphadenopathy, Vaccination site paraesthesia
Clinical narrative: woke up around 4-5 in the morning scratching at her neck; an itchy rash that was on her neck and extended to the back of neck, down to her stomach, legs, head, clavicles, and anywhere she can reach; injection site is tingling and pringling; lymph nodes in her right arm is swollen; This spontaneous case was reported by an other health care professional and describes the occurrence of PRURITUS (woke up around 4-5 in the morning scratching at her neck), RASH PRURITIC (an itchy rash that was on her neck and extended to the back of neck, down to her stomach, legs, head, clavicles, and anywhere she can reach), VACCINATION SITE PARAESTHESIA (injection site is tingling and pringling) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in her right arm is swollen) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included CARBAMAZEPINE (CARBATROL), LEVETIRACETAM DIHYDROCHLORIDE (KEPPRA [LEVETIRACETAM DIHYDROCHLORIDE]) and CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL SKIN ALLERGY RELIEF) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (woke up around 4-5 in the morning scratching at her neck), RASH PRURITIC (an itchy rash that was on her neck and extended to the back of neck, down to her stomach, legs, head, clavicles, and anywhere she can reach), VACCINATION SITE PARAESTHESIA (injection site is tingling and pringling) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in her right arm is swollen). The patient was treated with PREDNISONE ongoing since an unknown date at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (woke up around 4-5 in the morning scratching at her neck), RASH PRURITIC (an itchy rash that was on her neck and extended to the back of neck, down to her stomach, legs, head, clavicles, and anywhere she can reach), VACCINATION SITE PARAESTHESIA (injection site is tingling and pringling) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in her right arm is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 8 patients age range 12 to 18 received first dose Moderna Covid-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (8 patients age range 12 to 18 received first dose Moderna Covid-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (8 patients age range 12 to 18 received first dose Moderna Covid-19 vaccine). On 24-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (8 patients age range 12 to 18 received first dose Moderna Covid-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Caller received the 1st dose of the Moderna vaccine on May2021, 2 days later he got Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller received the 1st dose of the Moderna vaccine on May2021, 2 days later he got Covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caller received the 1st dose of the Moderna vaccine on May2021, 2 days later he got Covid-19). At the time of the report, COVID-19 (Caller received the 1st dose of the Moderna vaccine on May2021, 2 days later he got Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Received the  Johnson and Johnson  first; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received the  Johnson and Johnson  first) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received the  Johnson and Johnson  first). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received the  Johnson and Johnson  first) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Cough, Dyspnoea, Emphysema, Limb discomfort
Clinical narrative: Couldn't move the arm for a couple of days; pain; Sore arm; Emphysema COPD; Emphysema COPD; dry unproductive cough/it's just cough cough cough cough cough, and then I cough cough cough and you can't breath/up for half an hour and cough and cough; barely breath; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Couldn't move the arm for a couple of days), PAIN (pain), PAIN IN EXTREMITY (Sore arm), CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Emphysema COPD) and EMPHYSEMA (Emphysema COPD) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Couldn't move the arm for a couple of days), PAIN (pain), PAIN IN EXTREMITY (Sore arm), CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Emphysema COPD), EMPHYSEMA (Emphysema COPD), COUGH (dry unproductive cough/it's just cough cough cough cough cough, and then I cough cough cough and you can't breath/up for half an hour and cough and cough) and DYSPNOEA (barely breath). At the time of the report, LIMB DISCOMFORT (Couldn't move the arm for a couple of days), PAIN (pain), PAIN IN EXTREMITY (Sore arm), CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Emphysema COPD), EMPHYSEMA (Emphysema COPD), COUGH (dry unproductive cough/it's just cough cough cough cough cough, and then I cough cough cough and you can't breath/up for half an hour and cough and cough) and DYSPNOEA (barely breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medicines were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Couldn't move the arm for a couple of days; pain; Sore arm; Emphysema COPD; Emphysema COPD; dry unproductive cough/it's just cough cough cough cough cough, and then I cough cough cough and you can't breath/up for half an hour and cough and cough; barely breath; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Couldn't move the arm for a couple of days), PAIN (pain), PAIN IN EXTREMITY (Sore arm), CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Emphysema COPD) and EMPHYSEMA (Emphysema COPD) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Couldn't move the arm for a couple of days), PAIN (pain), PAIN IN EXTREMITY (Sore arm), CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Emphysema COPD), EMPHYSEMA (Emphysema COPD), COUGH (dry unproductive cough/it's just cough cough cough cough cough, and then I cough cough cough and you can't breath/up for half an hour and cough and cough) and DYSPNOEA (barely breath). At the time of the report, LIMB DISCOMFORT (Couldn't move the arm for a couple of days), PAIN (pain), PAIN IN EXTREMITY (Sore arm), CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Emphysema COPD), EMPHYSEMA (Emphysema COPD), COUGH (dry unproductive cough/it's just cough cough cough cough cough, and then I cough cough cough and you can't breath/up for half an hour and cough and cough) and DYSPNOEA (barely breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medicines were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat; This spontaneous case was reported by an other health care professional and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa drugs) and Penicillin allergy.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the patient was taking Botox and Fillers in the past for which dates are unknown (Medications unknown).  No treatment information was provided.   This case was linked to MOD-2021-268536 (Patient Link).
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Got Pfizer COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Got Pfizer COVID-19 vaccine) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Got Pfizer COVID-19 vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Got Pfizer COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported by the patient No treatment was received by the patient
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Anxiety, Decreased appetite, Panic attack, Tachyphrenia
Clinical narrative: Panic attack; Body shaky; Mind is racing; Stomach in knots; Lot of anxiety; Does not want to eat; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Panic attack), TREMOR (Body shaky), TACHYPHRENIA (Mind is racing), ABDOMINAL DISTENSION (Stomach in knots) and ANXIETY (Lot of anxiety) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced PANIC ATTACK (Panic attack), TREMOR (Body shaky), TACHYPHRENIA (Mind is racing), ABDOMINAL DISTENSION (Stomach in knots), ANXIETY (Lot of anxiety) and DECREASED APPETITE (Does not want to eat). At the time of the report, PANIC ATTACK (Panic attack), TREMOR (Body shaky), TACHYPHRENIA (Mind is racing), ABDOMINAL DISTENSION (Stomach in knots), ANXIETY (Lot of anxiety) and DECREASED APPETITE (Does not want to eat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Panic attack; Body shaky; Mind is racing; Stomach in knots; Lot of anxiety; Does not want to eat; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Panic attack), TREMOR (Body shaky), TACHYPHRENIA (Mind is racing), ABDOMINAL DISTENSION (Stomach in knots) and ANXIETY (Lot of anxiety) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced PANIC ATTACK (Panic attack), TREMOR (Body shaky), TACHYPHRENIA (Mind is racing), ABDOMINAL DISTENSION (Stomach in knots), ANXIETY (Lot of anxiety) and DECREASED APPETITE (Does not want to eat). At the time of the report, PANIC ATTACK (Panic attack), TREMOR (Body shaky), TACHYPHRENIA (Mind is racing), ABDOMINAL DISTENSION (Stomach in knots), ANXIETY (Lot of anxiety) and DECREASED APPETITE (Does not want to eat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Acne, Rash, Rash pruritic
Clinical narrative: He has had raised pimples on his arms, neck, thighs, top of his legs; Circular rash around his neck, itches like hell; Circular rash around his neck; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACNE (He has had raised pimples on his arms, neck, thighs, top of his legs), RASH PRURITIC (Circular rash around his neck, itches like hell) and RASH (Circular rash around his neck) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Heart disorder and Asthma. Concomitant products included ATENOLOL, CLOPIDOGREL, GABAPENTIN, AMLODIPINE, ATORVASTATIN, METFORMIN, MONTELUKAST, ZOLPIDEM, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), LOSARTAN, TAMSULOSIN and VITAMINS NOS for an unknown indication.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACNE (He has had raised pimples on his arms, neck, thighs, top of his legs), RASH PRURITIC (Circular rash around his neck, itches like hell) and RASH (Circular rash around his neck). The patient was treated with TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency and NYSTATIN at an unspecified dose and frequency. At the time of the report, ACNE (He has had raised pimples on his arms, neck, thighs, top of his legs), RASH PRURITIC (Circular rash around his neck, itches like hell) and RASH (Circular rash around his neck) outcome was unknown.            Concomitant medications include aspirin 81 mg. The patient received the both doses given by the local fire men in his building .  Treatment information includes a fungal powder Nystatin at night. He had been taking two topical medications and it stops and breaks out again. He went to the dermatologist and had told that it is the effect from the shot. He said that a bunch of his friends had it too.  The patient needs an advice that should he take a booster shot before he finds out how to treat what he has.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Influenza like illness, Joint swelling, Lymph node pain, Lymphadenopathy
Clinical narrative: Ankles and feet on both sides are incredibly swollen; Sore lymph node; Achy; Swollen lymph node; Highest fever reached 102.8F; Flu-like symptoms; Not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Not feeling well), JOINT SWELLING (Ankles and feet on both sides are incredibly swollen), LYMPH NODE PAIN (Sore lymph node) and MYALGIA (Achy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, LEVOTHYROXINE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), MONTELUKAST SODIUM (SINGULAIR), ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Not feeling well), LYMPH NODE PAIN (Sore lymph node), MYALGIA (Achy), LYMPHADENOPATHY (Swollen lymph node) and PYREXIA (Highest fever reached 102.8F). On 26-Jul-2021, the patient experienced JOINT SWELLING (Ankles and feet on both sides are incredibly swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Not feeling well), JOINT SWELLING (Ankles and feet on both sides are incredibly swollen), LYMPH NODE PAIN (Sore lymph node), MYALGIA (Achy), LYMPHADENOPATHY (Swollen lymph node) and PYREXIA (Highest fever reached 102.8F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jul-2021, Body temperature: 102.8 (High) 102.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also include high potency iron.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pyrexia
Clinical narrative: Ankles and feet on both sides are incredibly swollen; Sore lymph node; Achy; Swollen lymph node; Highest fever reached 102.8F; Flu-like symptoms; Not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Not feeling well), JOINT SWELLING (Ankles and feet on both sides are incredibly swollen), LYMPH NODE PAIN (Sore lymph node) and MYALGIA (Achy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, LEVOTHYROXINE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), MONTELUKAST SODIUM (SINGULAIR), ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Not feeling well), LYMPH NODE PAIN (Sore lymph node), MYALGIA (Achy), LYMPHADENOPATHY (Swollen lymph node) and PYREXIA (Highest fever reached 102.8F). On 26-Jul-2021, the patient experienced JOINT SWELLING (Ankles and feet on both sides are incredibly swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Not feeling well), JOINT SWELLING (Ankles and feet on both sides are incredibly swollen), LYMPH NODE PAIN (Sore lymph node), MYALGIA (Achy), LYMPHADENOPATHY (Swollen lymph node) and PYREXIA (Highest fever reached 102.8F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jul-2021, Body temperature: 102.8 (High) 102.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also include high potency iron.